RemSleep Holdings Inc. (RMSL) stock
Close on Oct 19, 2026Market cap –P/E –Yield –
RemSleep Holdings Inc. saw revenue fall 85.7% to $16.72K over fiscal 2025.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $16.72K
- Net income
- -$3.04M
- EPS, diluted
- $0.00
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 143,740
- Average volume (20 days)
- 1,578,996
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | RMSL | S&P 500 | Difference | RMSL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +3.6% | +0.6% | +2.9 pts | ||
| 3 months | -39.6% | +3.4% | −43.0 pts | ||
| Year to date | -14.7% | +13.3% | −28.0 pts | ||
| 1 year | -59.7% | +16.6% | −76.3 pts | ||
| 3 years | -89.3% | +86.4% | −175.7 pts | -52.6% | +23.1% |
| 5 years | -94.2% | +81.9% | −176.1 pts | -43.4% | +12.7% |
| 10 years | -99.9% | +318.9% | −418.7 pts | -48.9% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases RemSleep filed with the SEC as exhibits to Form 8-K or 6-K
About RemSleep
Services-Personal Services
REMSleep Holdings, Inc. develops and distributes medical devices for respiratory therapy, specializing in products for individuals suffering from obstructive sleep apnea. Its core offering is the DeltaWave CPAP interface, a patented nasal-pillows mask engineered to treat sleep apnea patients by improving user comfort and reducing the work of breathing. The company targets durable medical equipment providers, hospitals, acute care facilities, sleep laboratories, and physicians specializing in sleep and neurology, with durable medical equipment suppliers and hospitals representing its primary anticipated revenue channels.
Company profile, executives and historyRemSleep stock: common questions
What is RemSleep's stock price?
RMSL closed at $0.00 on Oct 19, 2026, up 5.84% on the day.
What is RMSL's P/E ratio?
RemSleep lost money over fiscal 2025 (diluted EPS $0.00), so it has no meaningful P/E ratio.
How much revenue does RemSleep make?
RemSleep reported revenue of $16.72K for fiscal 2025, down 85.7% from a year earlier.
Does RemSleep pay a dividend?
No. RemSleep has not paid a cash dividend over the last twelve months.
How has RMSL stock performed over the past year?
Including dividends, RMSL returned -59.7% over the past year, against +16.6% for the S&P 500.
Who are RemSleep's competitors?
Companies most similar to RemSleep by business, industry and size include BGFR, BDPT, YBGJ, GIPL, PRFX.
See a number that looks wrong?